Singapore markets closed

GeneDx Holdings Corp. (WGS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.78+0.01 (+0.03%)
At close: 04:00PM EDT
28.50 -0.28 (-0.97%)
After hours: 07:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close28.77
Open28.61
Bid28.70 x 100
Ask28.91 x 200
Day's range28.32 - 29.11
52-week range1.16 - 29.11
Volume215,973
Avg. volume467,149
Market cap752.623M
Beta (5Y monthly)2.29
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

    -- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on accelerating utilization of rWGS services in neonatal intensive care units (NICUs) -- STAMFORD, Conn., June 10, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that it is expanding access to its rapid whole genome sequenci

  • GlobeNewswire

    GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

    STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient access program, developed in partnership with leading biopharma companies, which aims to increase access to exome sequencing for pediatric epilepsy patients. “Receiving a genetic diagnosis can be critical in a child’s journey toward effective treatment and care, and we are thrilled our biopharma counterpar

  • GlobeNewswire

    GeneDx to Participate in Upcoming Investor Conferences

    STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference - New York City, New York Fireside chat on Wednesday, June 5 at 9:00 a.m. ET44th Annual Goldman Sachs Global Healthcare Conference - Miami, Florida Fireside chat on Monday, June 10 at 3:20 p.m. ET Live and archived webc